Home » Newsletters » BioWorld Science

BioWorld Science

March 30, 2020

View Archived Issues

New mouse model of MLL-ENL-driven AML to understand the early stages of leukemogenesis

Discovery of amide-linked benzimidazole-benzoxaborole hybrids for the treatment of onchocerciasis

Caelum initiates phase II study of CAEL-101 in AL amyloidosis

Phase II results for pembrolizumab in patients with advanced rare cancers

miR15a-1 as a new a noninvasive biomarker for asthma

Sepsis study may yield new treatment strategies

Dead cells do tell tales

TET1 gene therapy patented by the Military Medical Institute Academy

How lung tumors seed to brain

Roche synthesizes new TLR7/TLR8/TLR9 antagonists

Medshine Discovery discovers drugs targeting protein cereblon

New geranylgeranyl transferase type 1 inhibitors identified at Bayer

Abbisko Therapeutics identifies new fibroblast growth factor receptor inhibitors

Investigators describe biomarkers of liver injury

Gimsilumab completes phase I study in development of gimsilumab for COVID-19-related ARDS

NGM studies NGM-395 in obese adults and patients with NAFLD

New Chinese phase I study evaluates Ad5-nCoV coronavirus vaccine

Lundbeck discontinues foliglurax program in Parkinson's following phase IIa results

FDA approves new intravenous formulation of Triferic

Lundbeck reports phase IIa results with Lu-AG06466 in Tourette's syndrome

FDA approves Imfinzi as first-line treatment for extensive-stage SCLC

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Pre-disease plasma signature may help redefine lung cancer risk
BioWorld
Researchers have identified a 14-protein blood signature that can predict lung cancer risk as much as five years before diagnosis, and the findings could help...
New 5-HT2C receptor agonists reported in Hansoh patent
BioWorld Science
Researchers from Jiangsu Hansoh Pharmaceutical Group Co. Ltd. and Shanghai Hansoh Biomedical Co. Ltd. have disclosed tricyclic compounds acting as 5-HT2C receptor...